EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| ChEBI ID | CHEBI:747353 |
| ChEBI Name | darolutamide |
| Stars | |
| Definition | An androgen receptor antagonist that blocks androgen receptor nuclear translocation. It is used for the treatment of non-metastatic castration-resistant prostate cancer in men. |
| Last Modified | 13 February 2026 |
| Formula | C19H19ClN6O2 |
| Net Charge | 0 |
| Average Mass | 398.854 |
| Monoisotopic Mass | 398.12580 |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| darolutamide (CHEBI:747353) is a organic molecular entity (CHEBI:50860) |
| IUPAC Name |
|---|
| N-[(1S)-2-[3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl]-1-methylethyl]-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide |
| Synonyms | Source |
|---|---|
| BAY-1841788 | ChemIDplus |
| ODM-201 | ChemIDplus |
| Brand Name | Source |
|---|---|
| Nubeqa | DrugBank |
| Registry Numbers | Sources |
|---|---|
| CAS:1297538-32-9 | CAS |